These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma]. Yuan J, Han GH. Zhonghua Gan Zang Bing Za Zhi; 2023 Jan 20; 31(1):35-41. PubMed ID: 36948847 [Abstract] [Full Text] [Related]
28. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC. Am J Surg Pathol; 2010 Jan 20; 34(1):27-34. PubMed ID: 19898228 [Abstract] [Full Text] [Related]
30. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. Varotti G, Gondolesi GE, Roayaie S, Suriawinata A, Soltys K, Fishbein TM, Schwartz ME, Miller C. J Am Coll Surg; 2003 Nov 20; 197(5):765-9. PubMed ID: 14585411 [Abstract] [Full Text] [Related]
39. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC. Am J Surg Pathol; 2007 Jun 20; 31(6):907-13. PubMed ID: 17527079 [Abstract] [Full Text] [Related]